Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents
Key Points. Number of NAs used prior to alloHCT and NA immediately preceding alloHCT do not impact survival outcomes.Hematopoietic cell transplantation-specifi
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 August 2020
|
| In: |
Blood advances
Year: 2020, Volume: 4, Issue: 16, Pages: 3977-3989 |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2020001956 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2020001956 Verlag, lizenzpflichtig, Volltext: https://ashpublications.org/bloodadvances/article/4/16/3977/463451/Allogeneic-stem-cell-transplantation-for-chronic |
| Author Notes: | Lindsey E. Roeker, Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, Catherine C. Coombs, Haesook T. Kim, Matthew Davids, Steven T. Manchini, Gemlyn George, Nirav Shah, Timothy J. Voorhees, Kim H. Orchard, Harriet S. Walter, Arvind K. Arumainathan, Andrea Sitlinger, Jae H. Park, Mark B. Geyer, Andrew D. Zelenetz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, and Anthony R. Mato |
| Summary: | Key Points. Number of NAs used prior to alloHCT and NA immediately preceding alloHCT do not impact survival outcomes.Hematopoietic cell transplantation-specifi |
|---|---|
| Item Description: | Gesehen am 29.09.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2020001956 |